Year archive

NexgenRx Inc. — 2026 filings

All 10 regulatory filings released by NexgenRx Inc. (NXG) in 2026, sourced directly from the official regulator.

10 Filings

2026 Period

2026 filings (10)

Filing	Released	Lang
News release - English.PDF Notice of Dividend Amount	2026-04-17	English
News release - English.PDF Earnings Release FY 2025	2026-04-01	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-03-31	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-03-31	English
52-109FV1 - Certification of annual filings - CFO (E).PDF Regulatory Filings	2026-03-31	English
52-109FV1 - Certification of annual filings - CEO (E).PDF Regulatory Filings	2026-03-31	English
Annual MD&A - English.PDF Management Reports	2026-03-31	English
Audited annual financial statements – English.PDF Audit Report / Information FY 2025	2026-03-31	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2026-03-31	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2026-03-31	English